Home | Site Map | FAQ | Contact Us | Email Alerts | Employment
  
Printer Friendly

Presentations

Efficacy and impact on renal function of voclosporin (ISA247): The phase 2 'PROMISE' trial in de novo renal transplant recipients September 26, 2008  
Presented by: Dr. Marcelo Cantarovich, Medical Director of Kidney and Kidney-Pancreas Transplant Programme, Royal Victoria Hospital
Voclosporin (ISA247): The Phase 2 'PROMISE' de dovo Renal Transplant Trial Demonstrates Efficacy And An Improved Safety Profile Across a Wide Therapeutic Range - Poster Presentation August 14, 2008  
Presented by Dr. Stephan Busque, Associate Professor of Surgery and Director, Adult Kidney & Pancreas Transplant Program, Stanford University School of Medicine
Voclosporin (ISA247): The Phase 2 'PROMISE' de novo Renal Transplant Trial Demonstrates Efficacy And An Improved Safety Profile Across A Wide Therapeutic Range August 14, 2008  
Presented by Dr. Stephan Busque, Associate Professor of Surgery and Director, Adult Kidney & Pancreas Transplant Program, Stanford University School of Medicine
Using Voclosporin Pharmacokinetics (Concentration) and Pharmacodynamics (Calcineurin Activity) to Predict Optimum Immunosuppression in a Phase 2b Renal Transplantation Trial. August 12, 2008  
Presented by Dr. Herwig Ulf Meier-Kriesche, Professor of Medicine and Clinical Director of Renal Transplant in the Department of Medicine, University of Florida.
Ocular Distribution and Pharmacokinetics of LX214, a Clear Micellar Topical Formulation of Voclosporin, a Novel Calcineurin Inhibitor, After Single or Multiple Ocular Administrations in Rabbits July 31, 2008  
Voclosporin (LX211) Suppresses Anti-CD3 Activated Human T-Cell Proliferation and Effectively Treats Experimental Autoimmune Uveitis in Rats April 30, 2008  
Poster presented by the National Eye Institute
Development and Characterization of a Clear, Mixed Micellar Formulation of voclosporin, a Next Generation Calcineurin Inhibitor, for Treatment of Keratoconjunctivitis (Dry Eye Syndrome) April 28, 2008  
Presented by Prof. Ashim Mitra and colleagues from the University of Missouri, Kansas City
LUMINATE Trial Design April 28, 2008  
J.T. Rosenbaum, M.D. from the Casey Eye Institute-OHSU, Portland, Oregon, on behalf of the international LUMINATE Study Group.

 
Isotechnika Corporate Presentation April 14, 2008  
Applications of Calcineurin Based PK-PD in the Development of a New Immunosuppressant Voclosporin April 4, 2008  
Last updated September 26, 2008